D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 97 Citations 42,614 404 World Ranking 473 National Ranking 286
Medicine D-index 97 Citations 43,089 429 World Ranking 5531 National Ranking 3058

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Acquired immunodeficiency syndrome

John W. Mellors spends much of his time researching Virology, Immunology, Acquired immunodeficiency syndrome, Viral load and Viremia. The concepts of his Virology study are interwoven with issues in Reverse transcriptase and Genotype. John W. Mellors has included themes like Drug, MEDLINE and Antiretroviral therapy in his Immunology study.

His work deals with themes such as Viral disease, Clinical research, Drug resistance and Intensive care medicine, which intersect with Acquired immunodeficiency syndrome. His work is dedicated to discovering how Viral load, Internal medicine are connected with Gastroenterology, Reverse-transcriptase inhibitor and Oncology and other disciplines. The study incorporates disciplines such as RNA and In vivo in addition to Virus.

His most cited work include:

  • Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection (1843 citations)
  • Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy (1665 citations)
  • Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel (713 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Virology, Immunology, Internal medicine, Virus and Viral load. His biological study spans a wide range of topics, including RNA, Reverse transcriptase and Drug resistance. He focuses mostly in the field of Reverse transcriptase, narrowing it down to matters related to Molecular biology and, in some cases, RNase H.

His Immunology research is multidisciplinary, incorporating perspectives in Acquired immunodeficiency syndrome and Antiretroviral therapy. Efavirenz is closely connected to Reverse-transcriptase inhibitor in his research, which is encompassed under the umbrella topic of Internal medicine. His work in Zidovudine covers topics such as Lamivudine which are related to areas like Indinavir.

He most often published in these fields:

  • Virology (51.55%)
  • Immunology (28.09%)
  • Internal medicine (19.07%)

What were the highlights of his more recent work (between 2017-2021)?

  • Virology (51.55%)
  • Antiretroviral therapy (12.37%)
  • Internal medicine (19.07%)

In recent papers he was focusing on the following fields of study:

John W. Mellors mainly investigates Virology, Antiretroviral therapy, Internal medicine, Viremia and RNA. His Virology study focuses on Virus in particular. His Virus research integrates issues from T cell, Monoclonal antibody and Drug resistance.

His Antiretroviral therapy study combines topics from a wide range of disciplines, such as Proviral dna and Viral load. John W. Mellors has researched Internal medicine in several fields, including HIV drug resistance, Acquired immunodeficiency syndrome and Oncology. In his research on the topic of Cohort, Cytotoxic T cell is strongly related with Immunology.

Between 2017 and 2021, his most popular works were:

  • Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting (70 citations)
  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies (61 citations)
  • Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. (42 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Virus

His primary scientific interests are in Virology, Antiretroviral therapy, Viral load, Virus and RNA. His Virology research includes themes of Antibody, Glycoprotein and Provirus. His Viral load study incorporates themes from Viral suppression, Regimen, Lamivudine, Emtricitabine and Pediatrics.

His research in Lamivudine tackles topics such as Raltegravir which are related to areas like Internal medicine. His Emtricitabine research focuses on subjects like Young adult, which are linked to Cohort, Immunology, Clinical trial and Acquired immunodeficiency syndrome. The Virus study combines topics in areas such as Peripheral blood mononuclear cell, Art initiation and Monoclonal antibody.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

John W. Mellors;Charles R. Rinaldo;Phalguni Gupta;Roseanne M. White.
Science (1996)

3451 Citations

Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

John W. Mellors;Alvaro Muñoz;Janis V. Giorgi;Joseph B. Margolick.
Annals of Internal Medicine (1997)

2747 Citations

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

R M Gulick;J W Mellors;D Havlir;J J Eron.
The New England Journal of Medicine (1997)

2391 Citations

Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion

John W. Mellors;Lawrence A. Kingsley;Charles R. Rinaldo;John A. Todd.
Annals of Internal Medicine (1995)

1238 Citations

HIV sequence compendium 2002

Carla Kuiken;Brian Foley;Eric Freed;Beatrice Hahn.
(2002)

864 Citations

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

Sharon A. Riddler;Richard Haubrich;A. Gregory DiRienzo;Lynne Peeples.
The New England Journal of Medicine (2008)

853 Citations

Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer.
JAMA (2000)

828 Citations

Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

M S Hirsch;B Conway;R T D'Aquila;V A Johnson.
JAMA (1998)

731 Citations

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

Sarah Palmer;Frank Maldarelli;Ann Wiegand;Barry Bernstein.
Proceedings of the National Academy of Sciences of the United States of America (2008)

719 Citations

Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

F. Maldarelli;X. Wu;L. Su;F. R. Simonetti.
Science (2014)

715 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John W. Mellors

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 219

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 207

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 178

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 174

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 171

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 126

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 120

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 119

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 117

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 112

Javier Martinez-Picado

Javier Martinez-Picado

University of Vic

Publications: 107

Kenneth A. Freedberg

Kenneth A. Freedberg

Harvard University

Publications: 102

David A. Cooper

David A. Cooper

University of New South Wales

Publications: 99

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 93

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 91

David M. Margolis

David M. Margolis

University of North Carolina at Chapel Hill

Publications: 84

Trending Scientists

Matthew S. Reynolds

Matthew S. Reynolds

University of Washington

Deng-Ke Yang

Deng-Ke Yang

Kent State University

Emmanuelle A. Marquis

Emmanuelle A. Marquis

University of Michigan–Ann Arbor

Øystein Varpe

Øystein Varpe

University of Bergen

Anne-Marie Chèvre

Anne-Marie Chèvre

University of Rennes

Yuji Mishina

Yuji Mishina

University of Michigan–Ann Arbor

Paul N. Adler

Paul N. Adler

University of Virginia

Sanjay K. Nigam

Sanjay K. Nigam

University of California, San Diego

Peter J. Lenting

Peter J. Lenting

University of Paris-Saclay

Michael B. Robinson

Michael B. Robinson

Children's Hospital of Philadelphia

Adrian McDonald

Adrian McDonald

University of Leeds

Mario Amore

Mario Amore

University of Genoa

Rendon C. Nelson

Rendon C. Nelson

Duke University

David Saadoun

David Saadoun

Université Paris Cité

Claudia Aradau

Claudia Aradau

King's College London

Paul J. Green

Paul J. Green

Harvard University

Something went wrong. Please try again later.